Nachiappan Subramanian - May 16, 2025 Form 3 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Director
Signature
By: /s/ Nachi Subramanian
Stock symbol
ATRA
Transactions as of
May 16, 2025
Transactions value $
$0
Form type
3
Date filed
5/23/2025, 04:01 PM
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Subramanian Nachiappan Director C/O REDMILE GROUP, LLC ONE LETTERMAN, DRIVE, BUILDING D SUITE D3-300, SAN FRANCISCO By: /s/ Nachi Subramanian 2025-05-23 0002069599

No securities are beneficially owned.

Remarks:

Mr. Nachi Subramanian is a managing director of Redmile Group, LLC ("Redmile"), and was appointed to the Issuer's board of directors as a representative of Redmile and its affiliates. As a result, each of Redmile and Jeremy Green, as principal of Redmile, is a director by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.